Single cell profiling of female breast fibroadenoma reveals distinct epithelial cell compositions and therapeutic targets
Open Access
- 16 June 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-12
Abstract
Fibroadenomas (FAs) are the most common breast tumors in women. No pharmacological agents are currently approved for FA intervention owing to its unclear mechanisms and a shortage of reproducible human models. Here, using single-cell RNA sequencing of human FAs and normal breast tissues, we observe distinct cellular composition and epithelial structural changes in FAs. Interestingly, epithelial cells exhibit hormone-responsive functional signatures and synchronous activation of estrogen-sensitive and hormone-resistant mechanisms (ERBB2,BCL2andCCND1pathways). We develop a human expandable FA organoid system and observe that most organoids seem to be resistant to tamoxifen. Individualized combinations of tamoxifen with ERBB2, BCL2 or CCND1 inhibitors could significantly suppress the viability of tamoxifen-resistant organoids. Thus, our study presents an overview of human FA at single-cell resolution that outlines the structural and functional differences between FA and normal breast epithelium and, in particular, provides a potential therapeutic strategy for breast FAs.Keywords
Funding Information
- National Key R&D Program of China
- National Natural Science Foundation of China (81972598, 82273337)
- Natural Science Foundation of Zhejiang Province (LQ20H1600)
- Fundamental Research Funds for the Central Universities
This publication has 22 references indexed in Scilit:
- Breast fibroadenomas in adolescents: current perspectivesAdolescent Health, Medicine and Therapeutics, 2015
- Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenomaNature Genetics, 2014
- Breast diseases during pregnancy and lactationObstetrics & Gynecology Science, 2013
- High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancerInternational Journal of Cancer, 2009
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriersNature Medicine, 2009
- Genome-Wide Analysis for Loss of Heterozygosity in Primary and Recurrent Phyllodes Tumor and Fibroadenoma of Breast using Single Nucleotide Polymorphism ArraysBreast Cancer Research and Treatment, 2006
- Management of breast fibroadenomasJournal of General Internal Medicine, 1998
- A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene familyBreast Cancer Research and Treatment, 1996
- Long-Term Risk of Breast Cancer in Women with FibroadenomaNew England Journal of Medicine, 1994
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987